Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Classical hematology 3Plasma cell 2Other hematologic neoplasm 2Lymphoid 2Gynecologic 1

Conditions

Multiple Myeloma 2Lymphoma, Non-Hodgkin 2Leukemia, Lymphocytic, Chronic, B-Cell 2Anemia 2Neoplasms, Plasma Cell 1Neoplasms 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Leukemia 1

Interventions

Epoetin Alfa 10Darbepoetin alfa 4Therapeutics 2Filgrastim 2Ferric Oxide, Saccharated 2Cyclophosphamide 2Busulfan 2venetoclax 1trametinib 1ruxolitinib 1reolysin 1regorafenib 1ponatinib 1pertuzumab 1pembrolizumab 1palbociclib 1olaparib 1neratinib 1lorlatinib 1lenvatinib 1idelalisib 1fludarabine phosphate 1fludarabine 1ferrous sulfate 1ferric gluconate 1epoetin beta 1enzalutamide 1entrectinib 1enasidenib 1durvalumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Anemia × Ferric Oxide, Saccharated × Plasma cell × Clear all
NCT00482716 2014-01-10

Epoetin Alfa or Epoetin Beta With or Without Iron Infusion in Treating Anemia in Patients With Cancer

National Cancer Institute (NCI)

Phase 3 Unknown
80 enrolled
Classical hematologyLymphoidOther hematologic neoplasmPlasma cell

Anemia, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Marginal Zone, Neoplasms, Plasma Cell

NCT00145652 2007-07-30

Adjuvant I.V. Iron Therapy During Erythropoetin Treatment of Anemic Patients With Lymphoproliferative Disorders.

Sundsvall Hospital

Phase 3 Completed
66 enrolled
Classical hematologyLymphoidOther hematologic neoplasmPlasma cell

Anemia, Lymphoma, Non-Hodgkin, Multiple Myeloma, Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡